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Abstract
Objectives: This study was conducted to assess the psychometric properties of the Persian version of the overall anxiety severity
and impairment scale (OASIS), a measure designed to evaluate the severity and functional impairments associated with clinical and
subsyndromal anxiety.
Methods: Using a descriptive-analytic framework, first, the OASIS was translated into Persian according to the forward-backward
translation guidelines. Then, a total of 463 students of Guilan University of Medical Sciences in the academic year 2017 - 18 were se-
lected using the convenience sampling method. Participants completed seven measures (i.e., OASIS, anxiety and stress subscales of
depression anxiety stress scales-21, Beck anxiety inventory, openness subscale of NEO five-factor inventory, positive affect and nega-
tive affect scales, Connor-Davidson resilience scale, and state subscale of state-trait anxiety inventory), and the data were analyzed
by SPSS V. 20.0 for windows and Lisrel V. 8.80.
Results: Internal consistency reliability of the OASIS was acceptable (Cronbach’sα= 0.877). The exploratory factor analysis indicated
that all items were loaded on a single factor (loadings = 0.799 - 0.849). The confirmatory factor analysis revealed that the single-factor
model has resulted in an adequate model fit. The OASIS was positively correlated with the anxiety- and negative affect-related scales,
whereas it was negatively correlated with the resilience- and positive affect-related scales. Correlations with the openness subscale
were not significant.
Conclusions: In line with previous studies, the findings showed that the psychometric properties of the Persian version of the OASIS
are acceptable. Therefore, it seems that the measure can be used in clinical practices and research studies in Iran.
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1. Background
Similar to other countries, anxiety-related disorders
are common in Iran (1, 2). According to the findings of the
Iranian Mental Health Survey (1), the 12-month prevalence
of anxiety disorder is 15.6%. The 12-month and lifetime
prevalence estimates of anxiety disorders in the United
States are 18.1 (3) and 28.8% (4), respectively. While in 6 Eu-
ropean countries (Belgium, France, Italy, Germany, Nether-
lands, and Spain) these were around 6.4 and 13.6%, respec-
tively (2). Anxiety disorders, on the one hand, have long-
term effects on functional areas, and, on the other, often
co-occur with other psychiatric and medical diseases (5, 6).
Considering the high prevalence of anxiety disorders and
their functional consequences (7), measures are needed in
an assessment-based manner to evaluate anxiety disorders
in various clinical and research settings (8, 9).
Validated measures are often needed in a comprehen-
sive assessment of anxiety (10). Multiple measures have
been developed and validated for assessing anxiety during
the last decades (10). Many of these measures assess the
severity of anxiety based on the frequency of related symp-
toms, and enough attention is not paid to the functional
impairments caused by anxiety. Simultaneously, it is im-
portant to monitor how anxiety affects the patient’s daily
activities (11).
Insufficient attention to functional impairments
caused by anxiety may decrease the utility of scales for
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measuring the global effects of treatment (12). There-
fore, measures are needed to evaluate both severity and
functional impairment. Meanwhile, measures should be
short enough to be used in busy clinical settings. In recent
decades, a number of well-known self-report measures of
anxiety have been validated in Iran, including the Beck
anxiety inventory (BAI) (13) and state-trait anxiety inven-
tory (STAI) (14). Most of their items ask subjects about the
presence of the symptoms and do not explore the func-
tional impairments caused by anxiety-related symptoms.
In addition to the above measures, other measures have
also been validated that are related to functional impair-
ment, such as the work and social adjustment scale (WSAS)
(15) and Sheehan disability scale (SDS) (16). These measures
exclusively ask subjects about functional impairment or
disability and have no item about the frequency or severity
of the experienced symptoms.
Recently, Norman and colleagues (11) have developed
the overall anxiety severity and impairment scale (OASIS).
The OASIS is a 5-item self-report scale designed to assess
functional impairment caused by anxiety symptoms as
well as their frequency and severity. Specifically, the OA-
SIS was developed to meet the need for an anxiety measure
that could (a) measure directly the clinical severity and
functional impairment, (b) report transdiagnostically the
severity of any anxiety disorder, and (c) be short enough
(17). To date, this scale has been translated into Japanese
(18), Spanish (19, 20), and Dutch (12), and its psychometric
properties have been investigated in three studies on the
college student populations (8, 11, 21) and in eight studies
on the outpatient populations (8, 12, 17-20, 22, 23). These
studies supported its one-factor structure and showed that
it has robust reliability and validity. The applicability of
this scale for various clinical and subclinical levels of anxi-
ety and its specific emphasis on the functional impairment
caused by anxiety symptoms distinguish it from the more
conventional, longer anxiety measures (11, 12).
2. Objectives
Considering the high prevalence of anxiety disorders
in Iran (1), this research aims to evaluate the psychomet-
ric properties of the Persian version of the OASIS in a non-
clinical population (students of university) in Iranian soci-
ety.
3. Methods
3.1. Study Design, Participants, and Procedure
This research aimed to evaluate the psychometric
properties of the OASIS in an Iranian student population
using a descriptive-analytic study framework. The statisti-
cal population included all students of Guilan University
of Medical Sciences in the academic year 2017 - 18, and the
research sample (n = 463) was selected using the consec-
utive, convenience sampling method. The students were
included if they were interested in participating in the re-
search, and were excluded if they had auditory and/or vi-
sual deficits resulting in poor participation. According to
the ethical considerations, participation in the research
was voluntary and subject to the informed consent, and
necessary information was provided to the participants.
Ethical approval was obtained from the Iran University of
Medical Sciences Research Ethics Committee (ethical ap-
proval code: IR.IUMS.REC.1397.132). The order of the imple-
mentation of research instruments was random.
The first step was to validly translate the English ver-
sion to the Persian. So the following steps were taken
based on the guidelines of cross-cultural adaptation of self-
report measures (24): (a) forward-translating the English
version of the OASIS by two clinical psychologists; (b) in-
tegrating the forward-translations of the English version
of the OASIS by a third clinical psychologist (common-
translation version); (c) back-translating the common-
translation version by a specialist to the English language;
(d) interviewing with 10 students to ascertain to what ex-
tent is the Persian version of the OASIS understandable in
Iranian culture. Ultimately, the final version was prepared
for psychometric evaluations.
3.2. Measures
3.2.1. Overall Anxiety Severity and Impairment Scale
The OASIS is developed by Norman et al. (11) to specif-
ically measure the severity and functional impairments
caused by anxiety disorders and/or frequency and inten-
sity of anxiety; interference with work, school, and social
life; and impairment due to avoidance from situations,
objects, and activities (11). This scale consists of 5 items,
and each item contains 5 options, which are scored 0 to
4 and summed to obtain a total score. To date, this mea-
sure has been translated into Japanese (18), Spanish (19,
20), and Dutch (12), and its one-factor structure and robust
reliability (internal consistency and test-retest reliability),
and validity (convergent and divergent validity) have been
demonstrated in three studies on the college student pop-
ulation (8, 11, 21) and in eight studies on the outpatient pop-
ulation (8, 12, 17-20, 22, 23).
3.2.2. Depression Anxiety Stress Scales-21, Anxiety, and Stress
Subscales
Depression anxiety stress scales (DASS) uses a dimen-
sional approach to evaluate depression, anxiety, and stress
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symptoms (25). Many studies are conducted on evaluat-
ing its psychometric properties (26, 27). Also, studies per-
formed in Iran (28, 29) have supported its psychometric
characteristics.
3.2.3. Beck Anxiety Inventory
Beck anxiety inventory (BAI) is one of the most widely
used anxiety measures, which is investigated in many stud-
ies (30). In Iran, Kaviani and Mousavi (13) reported its valid-
ity as 0.72, test-retest reliability 0.83, and internal consis-
tency 0.92 for BAI.
3.2.4. NEO Five-Factor Inventory (NEO-FFI), Openness Subscale
The NEO five-factor inventory (NEO-FFI) is used to assess
the big five personality traits (neuroticism, extroversion,
openness, agreeableness, and conscientiousness) based on
the factor analysis approach (31). Neo-FFI’s reliability is ex-
cellent, and its convergent and discriminant validity has
been confirmed (31). In Iran, acceptable psychometric
properties have been reported on NEO-FFI (32).
3.2.5. Positive Affect and Negative Affect Scales
The positive affect and negative affect scales (PANAS)
has been developed to independently measure both posi-
tive affect (PA) and negative affect (NA) (33). Desirable psy-
chometric properties have been reported on PANAS in the
United States (33) and Iran (34).
3.2.6. Connor-Davidson Resilience Scale
This is a 25-item self-report measure on the ability to
cope stress. Its psychometric properties have been sup-
ported in some studies in the United States (35) and Iran
(36).
3.2.7. State-Trait Anxiety Inventory, State Scale
The state-trait anxiety inventory (STAI) consists of two
20-item measures of trait and state anxiety. The State sub-
scale assesses how respondents feel at the present moment
(37). The psychometric properties of this scale have been
confirmed in Iran (14).
3.3. Statistical Analysis
The psychometric properties of the OASIS were eval-
uated by assessing internal consistency and determining
the face, construct, convergent, and discriminant validity.
Analyses were performed using SPSS version 20.0 and Lis-
rel version 8.80.
4. Results
Descriptive statistics for demographic characteristics,
the total score of the OASIS, and the total score of other
measures are presented in Table 1. For 463 students who
participated in this study, the mean ± standard deviation
(SD) of age was 22.82 ± 3.28. 69/8% of participants were fe-
male and most of them (89/3%) were single. The mean± SD
of the OASIS score was 4.83 ± 3.68.
Table 1. Demographic and Clinical Characteristics of 463 Students








Private house 328 (71.5)
Leased house 131 (28.5)
Age 22.82 ± 3.28
Symptom severity
OASIS 4.83 ± 3.68
BAI 9.19 ± 8.87
STAI-State 40.20 ± 10.93
CDRISC 60.20 ± 17.83
NEO-Openness 21.02 ± 5.51
DASS-Anxiety 3.69 ± 3.60
DASS-Stress 7.09 ± 4.46
PANAS-P 31.73 ± 9.22
PANAS-N 18.83 ± 6.85
Abbreviations: BAI, Beck anxiety inventory; DASS-Anxiety, anxiety subscale of
depression anxiety stress scales; DASS-Stress, stress subscale of depression anx-
iety stress scales; OASIS, overall anxiety severity and impairment scale; CD-
RISC, connor-davidson resilience scale; NEO-Openness, openness subscale of
NEO five-factor inventory; PANAS-N, positive affect and negative affect schedule-
negative affect; PANAS-P, positive affect and negative affect scale-positive affect;
SATI-State, state subscale of state-trait anxiety inventory.
The internal consistency of the OASIS was assessed us-
ing Cronbach’s alpha coefficient. An α≥ 0.70 was consid-
ered as an acceptable internal consistency (38). As shown
in Table 2, the internal consistency reliability of the OASIS
was acceptable; Cronbach’s α for the five items of the OA-
SIS was 0.877 and it was more than 0.841, if each of the items
were omitted. The correlations between five items and be-
tween each item and the total score were statistically sig-
nificant at the .01 level. Moreover, its face validity was evalu-
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ated by gathering views of 10 students from the University
of Guilan.
The construct validity was evaluated using the EFA and
the CFA. The model fit was determined using the chi-square
test, the goodness of fit index (GFI), comparative fit in-
dex (CFI), non-norm fit index (NNFI), the root mean square
error of approximation (RMSEA), and standardized root
mean square residual (SRMR). The above indices were in-
terpreted based on the following proposed cutoff criteria
(39-41): Chi-square/df test between 2 and 5, GFI > 0.9, CFI >
0.90, NNFI > 0.90, RMSEA < 0.06, and SRMR < 0.08. The
EFA showed that all items loaded on a single factor (eigen-
value = 3.352, loadings = 0.799 - 0.849) and accounted for
67% of the variance (Table 2). The CFA revealed that a single-
factor model resulted in an adequate model fit: χ2/df =
3.05, P > 0.01; GFI = 0.91; SRMR = 0.06; RMSEA = 0.20, 90%
CI (0.09, 0.33); CFI = 0.92. Factor loadings showed that all
items were strongly related to this factor, with values rang-


















Figure 1. Confirmatory factor analysis model for the OASIS
Based on the literature (8, 11, 12, 17, 19-21), the positive
correlation of the Persian version of the OASIS with BAI,
Anxiety and Stress subscales of DASS-21, State subscale of
STAI and the Negative Affect subscale of PANAS was used
to evaluate the convergent validity, and its negative cor-
relation with Positive Affect subscale of PANAS, Openness
subscale of NEO and Connor-Davidson resilience scale (CD-
RISC) was used to determine the discriminant validity of
the OASIS. Studies have shown that those with low levels of
openness are often prone to chronic negative moods (42).
The results of the convergent and discriminant valid-
ity of the OASIS are reported in Table 3. The OASIS was pos-
itively correlated with the BAI (r = 0.546), state subscale of
the SATI (r = 0.555), anxiety subscale of the DASS (r = 0.503),
stress subscale of the DASS (r = 0.565), and negative affect
subscale of the PANAS (r = 0.458), whereas negatively corre-
lated with the CD-RISC (r = -0.428) and positive affect sub-
scale of the PANAS (r = -0.368). The correlation with the
openness subscale of the NEO-FFI (r = -0.082) was not sig-
nificant.
5. Discussion
The current study aimed to determine the psychome-
tric properties of the OASIS in the Iranian student popula-
tion. Previous studies have reported good validity and reli-
ability of the OASIS in clinical (both primary care and psy-
chiatric) populations (8, 12, 17-23). This study, in line with
the two previous studies (11, 21), showed acceptable psycho-
metric properties of the OASIS in the university students.
Our results provided some support for the reliability of
the OASIS. We obtained high Cronbach’s α (0.877) for the
internal consistency reliability of the OASIS. This finding is
in agreement with the results of the two previous research
on university students. Also, this finding is very close to
the findings of other studies conducted on clinical popu-
lations (8, 12, 22, 23). Regarding construct validity, in line
with previous studies (8, 11, 12, 17-23) that had demonstrated
the one-factor structure of the OASIS, the current study re-
vealed its unidimensionality. Specifically, we reached the
factor loadings of 0.799 - 0.849, which were very close to
the loadings reported in previous studies. We found that a
single-factor model gave the best fit for the data. The one-
factor structure of the OASIS suggested using total score
(computed by summing the five items) when it is to be
used in clinical and/or research situations (17).
This research provided adequate support for the con-
vergent validity of the OASIS. As we expected, it showed cor-
relations with well-established measures of anxiety. Pos-
itive correlations of the OASIS with BAI, State subscale of
STAI, and Anxiety and Stress subscales of DASS are fre-
quently replicated in previous research (8, 11, 12, 17-23). Also,
as repeatedly reported in the literature, the OASIS showed
convergent validity in correlation with the negative affect
subscale of PANAS, a construct that overlaps markedly with
the anxiety (17).
On the other hand, discriminant validity was sup-
ported by the negative correlations of the OASIS with CD-
RISC and positive affect subscale of PANAS, these findings
are well-documented in previous research (17, 19, 20). Re-
silience, a core construct of the CD-RISC, often is referred
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Table 2. Factor Analysis, Cronbach’s Alpha if Item Omitted, and Correlation Between Items for the OASIS
Cronbach’s α if Item Omitted Factor Loading Item 1 Item 2 Item 3 Item 4 Item 5 Total
Item 1. In the past week, how often have
you felt anxious?
0.856 0.799 1
Item 2. In the past week, when you have
felt anxious, how intense or severe was
your anxiety?
0.844 0.835 0.738a 1
Item 3. In the past week, how often did
you avoid situations, places, objects, or
activities because of anxiety or fear?
0.856 0.801 0.738a 0.546a 1
Item 4. In the past week, how much did
your anxiety interfere with your ability
to do the things you needed to do at
work, at school, or at home?
0.841 0.849 0.565a 0.565a 0.586a 1
Item 5. In the past week, how much
anxiety has interfered with your social
life and relationships?
0.854 0.809 0.518a 0.495a 0.556a 0.653a 1
Total 0.877 - 0.815a 0.849a 0.756a 0.795a 0.742a 1
Abbreviation: OASIS: overall anxiety severity and impairment scale
aP < 0.01
Table 3. Intercorrelations for Validity of the OASIS
OASIS CDRISC BAI STAI-State NEO-Openness DASS- Anxiety DASS- Stress PANAS-P PANAS-N
OASIS 1
CDRISC -0.428a 1
BAI 0.564a -0.445a 1
STAI-State 0.555a -0.640a 0.530a 1
NEO-Openness -0.082 -0.129 -0.002 -0.124 1
DASS- Anxiety 0.503a -0.445a 0.623a 0.551a -0.147b 1
DASS-Stress 0.565a -0.525a 0.581a 0.628a -0.139b 0.691a 1
PANAS-P -0.368a -0.581a -0.262a -0.552a -0.085 -0.220a -0.376a 1
PANAS-N 0.458a -0.277a 0.485a 0.474a -0.078 0.352a 0.435a -0.012 1
Abbreviations: BAI, Beck anxiety inventory; CD-RISC, Connor-Davidson resilience scale; DASS-Anxiety, anxiety subscale of depression anxiety stress scales; DASS-Stress,
stress subscale of depression anxiety stress scales; NEO-Openness, openness subscale of NEO five-factor inventory; OASIS, overall anxiety severity and impairment scale;




to as the reverse construct of anxiety and general distress,
and as it increases, the anxiety subsides (43). Besides, hav-
ing positive emotions has often been reported as a strong
protective characteristic against anxiety and depression
(44). We expected that the OASIS will show a negative cor-
relation with the openness subscale of NEO as with CD-
RISC and positive affect subscale of PANAS, although it had
only a non-significant association. This finding also was re-
ported by Norman and colleagues (11). This finding sug-
gests that although in some studies (44) openness is re-
ported to be positively correlated with positive emotions,
being prone to it is not necessarily associated with reduced
anxiety. Altogether, these data demonstrated that the OA-
SIS has adequate reliability, construct validity, and conver-
gent and discriminant validity in a non-clinical popula-
tion, and can be used for measuring the severity and im-
pairments related to various levels of anxiety.
5.1. Limitations
There were some limitations to this study. First, the age
and educational range of the study sample were very lim-
ited, which may have limited the generalizability of the re-
sults to other people in the older age range or those with
lower education. Second, only self-report measures were
used for assessing convergent validity. Therefore, the re-
sults may be affected by the method effect. Third, the inclu-
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sion of non-clinical samples in this study may have limited
the generalizability of the results to clinical groups. Future
studies on the OASIS should be designed to include a wider
age and educational range, using clinician-administered
tools or behavioral assessments in addition to self-report
measures, and including samples with clinical and/or sub-
clinical levels of anxiety.
5.2. Conclusions
In summary, the results demonstrate that the OASIS
has adequate reliability and validity to assess the severity
and functional impairments associated with the anxiety
in the university student population. These findings com-
plement the results of studies conducted on the OASIS in
the clinical populations. Given that assessment of func-
tional impairment is an integral component of the screen-
ing, diagnosing, and treating mental disorders and the OA-
SIS is the only measure specifically designed for assessing
functional impairments caused by anxiety (11), its psycho-
metric properties, along with its brevity, seem to enhance
its usefulness to be used in a variety of clinical and non-
clinical settings for measuring the anxiety-related severity
and functional impairments.
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